“The medicine is usually good. It’s the documentation that doesn’t support what’s being billed.” — Elizabeth Cifers

“With the algorithms CMS has now, [the question of whether you’ll be hit with an audit] is not an if — it’s a when.” — Elizabeth Cifers

“Compounded bevacizumab remains one of the most important access tools we have in retina.” — John Kitchens, MD

“The biggest issue for any of us is if buy-and-bill medicine disappears from our practices.” — Rishi P. Singh, MD

“We’ve been too focused on reactionary medicine and not enough on prevention.” — Rishi P. Singh, MD

“Anything that substantially disrupts drug pricing is going to have downstream consequences for practices.” — John Kitchens, MD

“The way we get paid for drugs is going to fundamentally change—and it’s going to change fast.” — John Kitchens, MD

“We’re not just doing contracts. We’re helping practices think strategically about how they operate.” — Shane Dixon

“Documentation isn’t optional anymore. ‘I didn’t know’ is not going to cut it.” — John Kitchens, MD

“We don’t want to be viewed as a distributor that picks, packs, and ships product. We want to be more than that, and we push ourselves to be more than that.” — Eric Besse

“If the soda fountain down the street puts two cherries on top, you put three. If they put three, you put four.” — Eric Besse, on his family’s philosophy of service

“If I were starting a practice today, [Cencora] would be the first place I would turn to partner.” — John Kitchens, MD

“I’m less worried about the shutdown itself — I’m worried about what happens afterward.” — Alexander Gaffney

“You might not be able to read or drive, but that peripheral vision is what lets you move through the world. Losing more of that matters.” — John Kitchens, MD

“We don’t always know what we’ve lost — how much faster certain drugs might have reached patients.” — Scott Krzywonos

“Eyecelerator isn’t just startups pitching. It’s where you see the future of medicine take shape.” – Scott

“Superiority studies could redefine what we consider durable therapy.” – John

“Cencora is like that guy in the background you don’t really know what he does… until you realize he’s keeping the whole system running.” – John

From the first eye transplant to the first therapy for geographic atrophy, Episode 1 sets the tone for RetinUp— candid, curious, and clinically relevant. Drs. Krzywonos and Kitchens explore how preparation meets luck, and how visionaries like Cedric Francois turn bold ideas into breakthroughs for patients.